IL6 and gastric cancer: Asporin has been shown to strongly inhibit apoptosis, promote growth in gastric cancer cells, and selectively promote LEF1 binding to activate the promoters of PTGS2, IL-6, and WISP1 to facilitate their transcription (Zhang et al., 2021).